Outcomes of Mitral Valve Repair Versus Replacement in the Elderly.
This study evaluated outcomes of mitral valve surgery (MVS) in the elderly. Patients 75 years or older undergoing MVS at a single center between 2010-2018 were included. Patients were stratified into mitral valve repair (MVr) or replacement (MVR). The primary outcome was mortality. Secondary outcomes included postoperative complications, readmissions, and freedom from at least moderate mitral regurgitation. Multivariable Cox regression was used for risk adjustment. A subanalysis of isolated, non-reoperative MVS for degenerative disease was also performed. 472 elderly patients underwent MVS: 301 (64%) MVr and 171 (36%) MVR. The majority of cases (68%) were performed for degenerative etiology. Survival was similar between MVr and MVR at 1-year (84% vs 86%, p=0.40) and 5-years (64% vs 64%, p=0.59). Postoperative complications were also comparable. Freedom from readmission was lower in the MVR cohort at 1-year (57% vs 68%, p=0.02) and 5-years (33% vs 43%, p=0.02). In isolated MVS for degenerative etiology, there was no difference in early or late mortality between MVr and MVR although readmissions were lower with MVr. Overall, freedom from mitral valve reoperation was comparable and the freedom from at least moderate regurgitation was 86% at 5-years in the MVr group. This study demonstrates that the outcomes of elderly patients undergoing MVS are acceptable with approximately 64% survival at 5 years. Our data suggests that MVr in the elderly may not confer a survival advantage but can be performed with durable results.